Exchange: NASDAQ·Updated 07:30 PM EST
AVXL logo

AVXL Anavex Life Sciences Corp

$0.85
$0.1159
(12.42%)
Today
Closed $0.8176
$0.0324
(3.96%)
After Hours
EarningsNov 24
Mkt Cap$86.53M
Vol2.72M

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
49

Neutral Sentiment

How do you feel about AVXL?

MayoMobile
$AVXL Acumen (ABOS) proving time and time again that amyloid reduction does not equal efficacy. Anavex needs to get moving. ⏰
48
TTTav66
$AVXL Curious observation: In the latest CTAD program update posted on Monday, Anavex staff has been removed from the presentation author block, leaving just the SAB members...Dr. Sabbagh who is presenting, Dr. Gabelle, and Dr. Grimmer. Were I to hazard a guess, keeping corporate staff off the listing is a deliberate move to frame the Col24a1/SIGMAR1 data as a clinician-led analysis. Having the poster authorship carried solely by respected academic neurologists may shift how the data is received on the conference floor.
1
39
straightforward
$AVXL We've gone from a CEO that in all earnestness could not even "Talk the Talk" to one who is mastering the "Walk the Walk." One can't emphasize enough the importance of demonstrating one's beliefs and promises through actions not words. Well done TK!
42
jrockford
$AVXL I wasn’t going to share, but ya think the shorts and hedge funds don’t know this? Lots of possibilities.., GLTA
23
Aurum81
$AVXL ... has done a lot right over the past few weeks. While there is still a lot of uncertainty and skepticism regarding future success, there will definitely be better days ahead.
36
Sand_Pebble
$AVXL This Is The Way. While I realize this great press release isn't enough to wipe away the previous negative sentiment the market has for AVXL, it is the right direction. A few more positive steps like this, all the missteps will be forgotten, eventually.
35
jrockford
$AVXL Is it possible? That anavex’s comprehensive, data-driven argument detailing blarcamesine’s safety, oral delivery, and efficacy, across Rett and Alz can allow the FDA (division of neurology) to potentially approve both Rett & Alz? Either immediate or accelerated? a) science — dual indication indicates upstream restoration of autophagy and cellular homeostasis via SIGMAR1 activation and impacts both neurodegeneration in alz and neurodevelopment in rett b) safety — dual indication of safety esp vs mabs and even Daybue c) NAIN— aligns w the NAIN directive to break traditional regulatory roadblocks for safe, non-traditional central nervous system (CNS) therapies DDI and ADME trials complete. Data being analyzed. They are needed for NDA. DDI trial size at 65(more than double what might be considered normal). Gotta be a good reason to do that… Let’s see. GLTA
34
Bn69111
$AVXL I’ll never be able to wrap my head around how a company that supposedly has such strong science could trade at .87 cents
1
17
jrockford
$AVXL FH established their initial position in q4 25. So their 2.6m stake is all within past year. There are similar others but at this point not as large. We know more Mon/Tue. Pvg actually decreased holdings 50%. So no exit. Shorts have covered ~17m shares over last year. Tute holdings up approx 5m in same period. Clearly some tax loss harvesting to offset some gains. 30 day rule required to buy back. Jan is historically good month for mid/small depressed stocks. Ball is in TK court…CTAD poster shoukd be out Monday for public access, Rett update soon and Alz update as well. 🤞 for FDA win. Company doesn’t need news, it needs good news. IMO, it’s coming. GLTA…
3
18
promenz
$AVXL It’s not easy to stay positive, but I don’t see any other sensible option. I am here to contribute something to the fight against dementia. Perhaps it was necessary to lose almost all my money to finally take action. Those who are already "full"—satisfied and comfortable—no longer feel the need to fight, and that is likely why everything moves so slowly. I am firmly convinced that a community with a shared interest can achieve anything—including financial success.
27
Trainguy1
$AVXL If we have 20 more 16% days in a row, the share price will be back at $28. After that we can go back to the normal appreciation .
29
ItsThrillhouse
$AVXL These studies were two things Chris should have done as a matter of simple professional and pharmaceutical competence. Analysis isn't even complete in a way we could know all is well, but if she wants to mention every small update as it happens, I'm definitely not mad about it.
29
rrogozin
$AVXL Let's not forget about the Abclear results, we may get a surprise from the FDA or potential partner. I still believe in the science and will continue adding.
28
ItsThrillhouse
$AVXL We can assume from consistent sharing that TK will immediately announce pediatric addition to Rett as soon as she knows in November. I feel as though this may be a small catalyst, as it/she may signal something broader about the FDAs evaluation of the previous Rett data and what it probably suggests is true about 2-73.
28
Barnstormer
$AVXL Best PR/good news we have had in a long time. Finally heading in the right direction 👆🥂 Still a long road ahead.
28
keyeaster2
$AVXL If I have learned anything over the last 18 months, it's that if your absolutely sure about something. Your probably wrong!
19
badprecog
$AVXL She needs to be the CEO in order to make a partnership deal, which would be what someone with a big pharma background would do. It is the playbook.
26
badprecog
$AVXL What should be the most valuable drug in human history, $12 million dollars if you subtract cash. Crazy.... but it is how you get rich.
26
badprecog
$AVXL In biotech the price always has to get ridiculously stupid, then you say well this is rock bottom, then go through that exercise about 3-4 more times then you hit rock bottom. But seems like 10 million for blarcamisine less cash is a pretty good deal.
25
Logic102
$AVXL I never did understand why we did not follow through with a second P3 Rett trial. Sure, Missling seduced us with the much larger TAM of AD, but he also promised not to drop Rett, he just left it and Parkinson's in some nebulous Purgatory--"we'll get to these very soon, trust me." The Rett follow up would have easy to do--short duration, pretty low cost and with learnings for the mixed results of the first trial. With success, it would have helped (a lot) the EMA to approve Blarcamesine for AD based on real world data. Missling probably feared a second failure might have cost him his job and he had many more years of salary to earn with a dragged-out AD process with the EMA. Tragic
24

Advertisement|Remove ads.